In March 2022, the Scottish Dental Clinical Effectiveness Programme (SDCEP) published the second edition of its guidance on the Management of Dental Patients Taking Anticoagulants or Antiplatelet Drugs.
This guidance is principally aimed at dentists, hygienists and therapists in primary care dental practice. It provides recommendations about the assessment of bleeding risk, treatment planning and management of patients who have been prescribed anticoagulants and antiplatelet drugs.
Endorsed by the Royal Colleges, and the College of General Dentistry, the guidance aims to promote the safe and effective provision of oral health care for this group of patients.
Updated recommendations from SDCEP
Dental practitioners will be aware of the risk of bleeding complications when they perform invasive dental procedures in patients taking anticoagulants or antiplatelet drugs. This updated guidance from SDCEP provides clear and practical advice to enable dental teams to manage this group of patients within primary care.
First published in 2015, the guidance aims to encourage a consistent and evidence-based approach to the dental management of patients taking these medications. The 2022 update incorporates current evidence to support the clinical practice recommendations. It was developed by a multidisciplinary group using SDCEP’s NICE-accredited methodology.
The Full Guidance is available from the SDCEP website.
The guidance includes recommendations about:
- Assessment of bleeding risk from dental treatment: Dental practitioners can refer to the guidance, which includes a table categorising dental procedures according to low or high risk of post-operative bleeding complications.
- Medical history: This should include questions about the patient’s use of medications, including anticoagulants or antiplatelet drugs, as well as medical conditions and bleeding history. The guidance advises delaying non-urgent, invasive procedures where possible for patients receiving time-limited anticoagulant or antiplatelet drugs. The full guidance also provides advice about the management of patients with other relevant medical complications, including when to consult with the patient’s prescribing clinician, specialist or GP.
- Treatment planning: For all patients taking anticoagulants or antiplatelet drugs who require dental treatment likely to cause bleeding, general advice is given regarding treatment planning to avoid complications, and provision of pre-treatment and post-treatment instructions to the patient.
- Management according to the type of anticoagulant or antiplatelet drug: Further advice is provided, specific for patients taking direct oral anticoagulants (DOACs), vitamin K antagonists such as warfarin, injectable anticoagulants (low molecular weight heparins), antiplatelet drugs, or a combination of anticoagulants/antiplatelet drugs.
Following a full review of the original 2015 guidance, many of the recommendations remain unchanged in this update. However, Steven Johnston, Senior Dental Officer, NHS Orkney, and Chair of the group that developed the updated guidance, commented:
“Prescribing of anticoagulants and antiplatelet drugs has increased since publication of the first edition of the guidance and dental practitioners are increasingly likely to encounter patients taking them, particularly the Direct Oral Anticoagulants or DOACs.”
“The second edition of the guidance provides up-to-date recommendations to continue to help clinicians manage dental care for these patients and includes the newer DOAC edoxaban and expanded advice about the low molecular weight heparins.”
This edition of the guidance is also the first SDCEP document to consider the potential environmental impact of its recommendations. The advice offered to support implementation of environmentally sustainable oral health is intended to minimise patient travel, a significant contributor to a dental practice’s carbon footprint:
- Confirm medical history in advance in case of changes that lead to postponement.
- Consult with the patient’s prescribing clinician, specialist or medical practitioner in advance, if required.
- Provide pre- and post-treatment patient instructions.
- Suture and pack at the time of treatment to avoid reattendance for postoperative bleeding.
Implementation and supporting resources
Reassuringly, a recent study by Woolcombe et al, looking at the implementation of the 2015 guidance, concluded that the recommendations were safe to follow – among a cohort of 98 patients who underwent 119 dentoalveolar procedures, none experienced major haemorrhage.
Yet, absolute compliance with the recommendations was achieved in less than half of cases. This suggests that dental staff need additional education and support to fully implement the guidance.
Helpfully, SDCEP provides supporting tools to assist with the implementation of the 2022 guidance:
Dental practitioners have a responsibility to make decisions appropriate for the individual patient, with the consent of the patient. Where significant departures from this guidance are deemed necessary, the SDCEP guidance advises that “the reasons for this, are documented in the patient’s clinical record”.
If you require dento-legal advice about the management of patients taking anticoagulants or antiplatelet drugs, please contact Dental Defence Society for expert support.
The British Dental Association (BDA) and others have long been calling for ambitious reform of NHS dental contracts. The pandemic has added urgency to the situation. With a huge backlog of patients requiring care and NHS dental practices struggling to meet activity targets, a new approach is needed to secure the future of NHS dentistry.
In England, the current contract system, based on units of dental activity (UDA), is widely criticised. The inflexibility of the contracts limits profitability when running costs are escalating and the system fails to address problems of staff retention, patient access and oral health inequality. Although some preliminary changes appear imminent in England, dentists will have to wait longer for a full overhaul of the system.
Progress is mixed across the other UK nations but a fully reformed contract has yet to be introduced anywhere. There are fears that continuing delays in reform may drive more dentists to leave NHS practice altogether.
Current status of NHS contract reform in England
In England, the process of reforming NHS dental contracts began in 2011, after the Steele Review (2009) recommended changes to improve access, continuity of care and focus on prevention. Since then, over 100 dental practices have participated in the Dental Contract Reform Programme to pilot test new ways of delivering NHS dentistry. However, it proved difficult to satisfy all stakeholders. Initial pilots increased satisfaction among dentists and patients but led to declines in access and activity. Later pilots designed to address these issues left dentists unhappy as profitability fell.
The programme was ended on 31 March 2022 and prototype contracts have now reverted to the standard contract based on UDA targets.
Although the outcomes and experiences of practices involved in pilot testing will inform the ongoing process to reform the contract, the BDA stated “It is profoundly disappointing that the prototype approach was abandoned in this way”.
Practices that participated in prototype testing are offered guidance and support from NHS Business Services Authority. However, the BDA has expressed concern that these practices could be financially disadvantaged and that the support provided is too limited.
The route to future contract reform
The complex process of reforming the dental contract in England continues with a new phase, begun in the summer of 2021. An advisory group reviewed the various contracting approaches with the aim of developing new proposals that will work for all stakeholders: clinicians, practices and NHS England.
NHS England and NHS Improvement have stated that to be viable, contract reform should meet the following aims:
- Be designed with the support of dentists
- Improve oral health outcomes
- Increase incentives for preventive dentistry and prioritise evidence-based care for high needs patients
- Improve access to NHS care, addressing inequalities
- Demonstrate that patients are not driven to pay privately for previously commissioned NHS dental care
- Be affordable within NHS resources.
The BDA is currently holding confidential discussions with NHS England, focusing on:
- Quick wins: “rapid, modest and marginal changes to existing national contractual arrangements”. Initial changes were expected to be announced in April 2022. In recent weeks, Minister Maria Caulfield MP assured colleagues in the House of Commons that she would announce some short-term contractual changes shortly.
- Long-term contract reform, with focus on care for high-needs patients, urgent care, fairness in rewarding dental activity, skill mix and teamwork, prevention, and making dental professionals feel valued within the NHS.
Long-term, the BDA is in favour of a capitation-based payment system that would support dentists to deliver prevention-focused care. However, dentists are likely to have to wait a considerable time for the roll out of any such system. The concern is that further delay may push more frustrated dentists to move from NHS practice into private practice.
Contract reform restarted in Wales
In Wales, dentists were informed in March that they could join a ‘test and modify’ reform programme if they chose to adopt a contract variation from 1 April 2022. The alternative choice was a return to UDA contract arrangements.
Under the variation, the UDA element is reduced and the balance of the contract can be met by performance against new metrics (fluoride varnish, new patient target, mandatory services to existing patients, recall intervals). This is viewed as the restart of the reform process, which will help to shape the future NHS contract for Wales.
Elsewhere in the UK, limited headway has been made. Contract discussions are underway in Northern Ireland but in Scotland, there is disappointment at the lack of progress.
If you need advice regarding NHS contracts, please do not hesitate to contact us at Dental Defence Society. Our advisers are available 24/7 to offer expert support.
Tooth whitening represents a safe and effective treatment option for many dental practices as patient demand is growing year on year. However, dentists often face a dilemma when asked to perform tooth whitening for patients under 18 years old. Discoloured teeth can have a serious and detrimental impact on young patients’ self-esteem and daily life. Yet a dentist’s ethical and legal duty of care towards their paediatric patients must be weighed against legal restrictions on this kind of treatment.
Legally, tooth-whitening products that contain or release more than 0.1% hydrogen peroxide should not be used on patients under 18. However, guidance from the General Dental Council (GDC) suggests that tooth-whitening treatment for under 18s may be acceptable under certain circumstances.
This leaves many dentists questioning how to interpret the rules and stay within the law while meeting their young patients’ needs.
What is the legal and regulatory position on tooth whitening?
The GDC tooth-whitening position statement makes it clear that, in line with the EU Cosmetics Regulation (Cosmetic Products Enforcement Regulations 2013), tooth whitening products with effective concentrations between 0.1% and 6% hydrogen peroxide must not be made available to consumers except by regulated dentists and their teams (dental hygienists, dental therapists or clinical dental technicians on the prescription of a dentist). These products can only be used following an appropriate clinical examination.
Furthermore, products producing concentrations exceeding 6% hydrogen peroxide are prohibited; those releasing less than 0.1% hydrogen peroxide are considered safe and are freely available.
For patients under 18 years of age, the EU Cosmetics Regulation states that products containing or releasing between 0.1% and 6% hydrogen peroxide are not to be used. However, GDC advises that is the case “except where such use is intended wholly for the purpose of treating or preventing disease”.
Breach of the regulations is a criminal offence and GDC may prosecute anyone carrying out tooth whitening illegally.
Interpretation of the GDC position
When it comes to treating patients under 18 years old, dentists may wonder how to interpret the somewhat contradictory rules.
The GDC position is that it would not raise concerns about fitness to practice where the tooth whitening performed by a dentist was “wholly for the purpose of treating or preventing disease”, but it provides no details on the exact clinical indications that might be covered. In response, Greenwall-Cohen et al (Br Dent J 2018:225:19–26) provided an evidence-based discussion of the safety, efficacy, indications and techniques for tooth whitening in under 18s.
The article proposed a list of indications for bleaching in under-18-year-old patients, including severe/moderate discolouration, enamel conditions, white markings, staining, coronal defects, molar incisor hypomineralisation, hereditary factors, trauma, and dental effects of systemic diseases.
The authors argue that, when used appropriately, tooth bleaching can achieve good results in adolescent patients with minimal side effects, and help to alleviate the psychological and psychosocial impacts of tooth discolouration.
Legal and ethical dilemmas
However, regardless of the GDC position, supplying a tooth-whitening product to a patient under 18 years old would constitute a criminal act based on the strict EU Cosmetics Regulation.
So even if tooth whitening treatment is performed in the best interests of the child for indications that can be argued to be wholly for treatment or prevention of disease, a dentist could still be subject to criminal action brought by Trading Standards or others.
This presents a frustrating ethical dilemma for dentists in situations where illegal tooth whitening for a paediatric patient might be in their best interests, for example to avoid the need for a more invasive procedure. Although the treatment may be justifiable in terms of ethical responsibility and clinical need, this may not provide a legal defence. Supplying the treatment could be breaking the law.
DDS members are advised to consult us if you find yourself in this difficult situation, before providing any treatment to under 18-year-olds.
If you need more information about the legal aspects of tooth whitening, please contact Dental Defence Society. We are ready to support members who need advice about this topic, including questions relating to the treatment of patients under 18 years of age.
Unfortunately, claims alleging failure to diagnose and treat periodontal disease top the list of legal action against dental professionals. Those subject to such litigation may find it a highly stressful experience, especially if it leads to investigation by the General Dental Council (GDC). Cases commonly involve multiple dental staff who treated a patient over several years, and many take a year or more to resolve. Settlement frequently involves large sums – over £25,000 in most cases, and often more than £100,000.
To avoid future claims related to periodontal diseases, dental professionals must follow relevant guidelines, communicate their findings with patients, and keep detailed records. Defence against such a claim is much more difficult if the patient’s records do not document relevant examinations, investigations and diagnoses, as well as advice and treatment.
UK classification of periodontal disease
Regular screening and early diagnosis are essential for managing periodontal disease and preventing tooth loss, with its consequent disabilities and health impacts. Importantly, periodontal disease can be asymptomatic even in advanced cases and is only identified by dental professionals.
To support clinicians in recognising and diagnosing the condition in general dental practice, a new international classification system for periodontal disease was agreed at the 2017 World Workshop. This was subsequently adapted and adopted for use in the UK by the British Society of Periodontology and Implant Dentistry (BSP).
UK dental professionals should refer to BSP’s UK Implementation, which classifies periodontal disease into stages based on severity (I, II, III or IV) and grades based on disease susceptibility (A, B or C).
As explained in the UK implementation of European S3-level treatment guidelines for stage I-III periodontitis, the clinical pathway for diagnosis of periodontitis includes 4 steps:
- Basic periodontal examination (BPE) screen (see BSP’s BPE guideline and Simplified BPE guideline for under 18s)
- Provisional diagnosis
- Further investigations (radiographs and detailed probing charts)
- Diagnostic statement. This includes: definitive diagnosis; extent (localised or generalised); stage and grade; current status (stable/unstable); and risk factors.
A BSP decision-making flowchart is available to help practitioners implement the classification.
Why clinical negligence cases arise
A substantial number of complaints, claims and even referrals to the GDC arise because of allegations that the treating dental professional(s) failed to examine, investigate, diagnose or properly treat periodontal disease. The usual three-year limitation period may not apply if a patient can demonstrate that they only recently learned of their condition.
Successful claims often hinge upon insufficient documentation. Even if the treating dental professional argues that they did assess, treat and inform the patient correctly, they will find it difficult to support that argument if the patient’s clinical records do not show a complete and accurate record.
Since the consequences of undiagnosed or improperly managed periodontitis may be serious, compensation pay-outs are often highly costly, including damages for pain and suffering, loss of teeth and damage to the jawbone, remedial treatment costs as well as loss of earnings. Dental professionals should be aware of the risk and protect themselves from future litigation.
Reduce the risk of damaging litigation for periodontal disease
Follow guidelines: Dental professionals can reduce the risk of being subject to a claim or complaint for failure to diagnose and treat periodontal disease by following the BSP guidelines on classification and treatment.
Perform regular screening: The BSP Parameters of Care statement emphasises that oral healthcare professionals have a responsibility to screen patients regularly for periodontal and peri-implant disease, using appropriate clinical investigations to aid diagnosis and formulation of a treatment plan.
Seek specialist help if required: Patients with periodontal diseases may be referred according to BSP guidelines for a specialist opinion to assist with patient management.
Communicate well: The BSP statement also stresses the importance of good communication between clinicians and patients. Following every assessment, dental professionals should take time to explain their findings to the patient and discuss all reasonable treatment options, obtaining informed consent where necessary.
Make detailed records: All periodontal assessments and findings should be recorded in a patient’s clinical records, along with details of any discussions with the patient. Even if the treatment plan requires only monitoring and oral hygiene instructions, notes of the discussion and advice given, as well as any follow-up, should be as detailed as possible. An article in BDJ Team provides some useful phrases to include in templates, which should always be personalised (Wadia R, D’Cruz L. Avoiding the pitfalls of dento-legal issues. BDJ Team 2018;5:18091).
Provide written information: Wadia and D’Cruz also suggest using written information leaflets, and if a patient is non-compliant, then it may help to write them a letter explaining the importance of treatment. Ensure these actions are recorded in the patient’s notes.
Manage complaints proactively: Any complaints should be handled quickly and proactively to limit the damage.
At Dental Defence Society, our dento-legal experts can provide timely advice about dealing with complaints and claims regarding periodontal disease. Please contact us for 24/7 support as soon as a case arises.
On 24th November, the UK Health Security Agency published new guidance for infection prevention and control (IPC) in health and care settings, focusing on seasonal respiratory viruses, especially COVID-19, influenza and respiratory syncytial virus. This guidance supersedes the previous UK IPC COVID-19 guidance.
The IPC Dental Appendix was also updated in line with the guidance. This applies to all areas of dentistry including both NHS dentists and private dental practices. The Chief Dental Officer (CDO) for England, Sara Hurley, subsequently published an updated SOP for dental teams, which has been updated to complement the IPC guidance.
The main change for dentists is the introduction of a risk-based, two-pathway approach. Dental practices and staff should make sure that they are aware of the changes and follow the new guidance to protect themselves and patients.
Key changes to the overall UK IPC guidance
The main changes to the UK IPC guidance include removal of the three COVID-19 specific care pathways (high, medium and low) and addition of a section on the criteria to be applied within the ‘hierarchy of controls’ to further support organisations/services with maximum workplace risk mitigation.
New recommendations to be aware of are:
- Universal use of face masks for staff and face masks/coverings for all patients/visitors within health and care settings over the winter period.
- Physical distancing should be at least 1 metre, increasing whenever feasible to 2 metres across all health and care settings.
- Physical distancing should remain at 2 metres where patients with suspected or confirmed respiratory infection are being cared for or managed.
- Screening, triaging and testing for SARS-CoV-2 should continue over the winter period. Testing for other respiratory pathogens will depend on the health and care setting according to local/country-specific testing strategies/frameworks and data.
New clinical pathways for dental practices
With removal of the three COVID-19 specific care pathways, the new guidance in the Dental Appendix recommends use of a screening tool to determine which of two clinical pathways patients should take within a dental practice.
Non-respiratory pathway (patient has answered NO to all screening questions):
- Complete the appointment applying standard infection control precautions (note: country-specific requirements may be in place for testing prior to aerosol generating procedures [AGPs]).
- Physical distancing should be at least 1 metre in all areas where possible, for example when not providing direct clinical care. Patients may sit in waiting rooms together provided a physical distance of at least 1 metre can be maintained. This should be increased to 2 metres whenever feasible.
- Face coverings are acceptable for patients.
- Dental treatments, both AGP and non-AGP, can go ahead without fallow time.
Respiratory pathway (patient has answered YES to one or more screening questions):
- If possible, based on a clinical assessment, reschedule the appointment until resolution of symptoms, the end of the isolation period or a negative test result.
- Transmission-based precautions (TBP) should be applied in addition to standard infection control precautions. This includes appropriate personal protective equipment (PPE) and respiratory protective equipment (RPE) according to the setting/treatment.
- Patients should be separated, in time or space, from patients on the non-respiratory pathway. Refer to local arrangements as to where treatment should be carried out.
- Provide patients with surgical masks type II or type IIR in place of a universal face covering.
- Physical distancing of at least 2 metres is required.
- For patients undergoing AGPs, TBPs apply and post-AGP downtime is required. Only essential staff necessary to undertake the procedure should be present.
- Carry out any AGP procedures at the end of the day or clinical session to minimise the impact of fallow time on other patients.
Implications of Omicron for IPC measures
With the current surge in COVID-19 cases and spread of the highly transmissible Omicron variant, dentists have questioned whether the new guidance still applies.
Sara Hurley provided an update, in which she wrote: “Dental practices should continue to see patients in line with our infection prevention control guidelines, with the standard operating procedure helping you implement them in practice.”
She added: ”if as new evidence emerges the IPC requirements need to change, the guidance will be updated.”
She also urged dental team members to get their COVID-19 vaccinations and booster. The Department of Health and Social Care has announced that individuals undertaking Care Quality Commission regulated activities in England must be fully vaccinated against COVID-19 by 1st April 2022. This will apply to staff in both NHS and private practices. NHS England has written to all dental practices with more details of the requirement.
The CDO also asked dentists to complete the England Dental Working Patterns Survey from NHS England to help better understand views on the challenges presented by the pandemic and the measures put in place (deadline Sunday 9 January).
Please do not hesitate to contact Dental Defence Society if you need dento-legal support related to infection control precautions.
Despite the well-known association of smoking with cancer and cardiovascular diseases, about 7m adults in the UK are current smokers. They may not realise that tobacco smoking also damages oral health, being a major risk factor for both oral cancer and periodontal disease.
Dental teams play an important role in prevention of oral cancer and periodontal disease, which includes supporting patients to quit smoking, alongside advice about good oral hygiene and diet. Routine appointments provide opportunities for asking about smoking as well as use of alternative tobacco and nicotine products, such as shisha and e-cigarettes.
Dental practitioners should be aware of such alternative forms of smoking, which are also linked to periodontal disease. For e-cigarettes, the issue is complex as, although not risk-free, they play a role in smoking cessation programmes.
Smoking is a major cause of periodontal disease
Periodontal disease is a leading cause of tooth loss, which can affect patients’ speech, nutrition and quality of life. It is also linked to various systemic diseases.
Family history, poor oral hygiene, stress, and smoking are all important risk factors. A recent systematic review estimated that tobacco smoking increases the risk of periodontitis by 85%. It also increases severity of periodontal disease and diminishes the treatment response.
However, many of the effects of smoking on oral tissues are reversible. Quitting smoking is one of the most important ways in which people can improve their oral health. Strong evidence shows that over time, patients who quit benefit from a reduced risk of periodontitis and tooth loss. The best way to quit is with a combination of specialist support and medication.
E-cigarettes: are they any better for oral health?
On the one hand, e-cigarettes are less harmful than conventional cigarettes and they can help people to quit smoking. In a Cochrane review, more people quit when using nicotine e-cigarettes than when using other nicotine replacement therapies (NRTs). More than 3 million people use e-cigarettes in Great Britain. The vast majority are ex-smokers or dual users, who vape to reduce their need for conventional cigarettes.
On the other hand, vaping is not risk free and non-smokers are not advised to take up vaping. A number of studies and anecdotal reports have raised concerns about deterioration in oral health, accelerated development of caries, and destruction of the periodontium and jaw bone among vapers. But e-cigarettes are a relatively recent innovation and evidence is sparse. Well-conducted, longitudinal studies are needed.
Shisha is not a safer alternative to smoking cigarettes
Shisha (tobacco waterpipe or hookah) is commonly misperceived to be less harmful than conventional smoking. However, shisha smoke contains levels of volatile organic compounds, ultrafine particles, nicotine, and carbon monoxide at least equivalent to cigarette smoke. Incredibly, shisha smokers can inhale over 40 litres of smoke in a single session, much more than from a single cigarette (up to 1 litre).
Like cigarette smokers, shisha smokers are at increased risk of developing oral cancer and periodontal disease and bone loss. As the popularity of shisha is increasing in the UK, especially among younger adults, dentists should ask patients about its use.
What are dental practitioners expected to do?
Dental practitioners are uniquely placed to support their patients in preventing oral cancer and periodontal disease. Public Health England published an updated guideline in September 2021: Delivering better oral health: an evidence-based toolkit for prevention.
Clinical assessment should include asking patients about use of tobacco and NRTs such as e-cigarettes. It is important to ask about alternative forms of tobacco (e.g. shisha, smokeless, nasal snuff) and use the names of products used locally.
For patients who do smoke, advice can be given about quitting smoking, as outlined in: Very brief advice pathway: 30 second discussion. This Very Brief Advice (VBA) from the dental team can increase a patient’s motivation to quit smoking and double their chances of success.
To avoid creating a defensive reaction, the VBA does not include warning patients about the dangers of smoking or advising them to stop. Instead, dental professionals should refer patients who want to stop to specialist support services where available, or to their GP or pharmacist.
The legal perspective
Further advice can be found in the Healthy gums do matter toolkit from the British Society of Periodontology and Implant Dentistry. This includes a valuable section on legal and ethical perspectives.
The advice emphasises the need to follow guidelines, communicate well with patients about their oral health, and keep detailed records of decisions and reasoning (especially if deviation from the guidelines is deemed to be in the patient’s interest). Following these principals will help in the event of a claim for clinical negligence regarding a patient’s periodontal health.
If you are a member needing dento-legal support for a complaint or claim related to a patient’s oral health, Dental Defence Society is available 24/7 to answer your call and provide advice.